SEC Form 4 · accession 0001209191-18-021563
SPECTRUM PHARMACEUTICALS INC · SPPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Mitchell Krassner
Director
Period of report
Mar 21, 2018
Accepted (ET)
Mar 23, 2018 · 6:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Mar 21, 2018 | M | 30,000 | $2.55 | A | 83,257 | D | |
| Common Stock, $0.001 par value | Mar 21, 2018 | S | 4,200 | $18.6376 | D | 79,057 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option Exercise (Right to Buy) | $2.55 | Mar 21, 2018 | M | 30,000 | D | Mar 25, 2009 | Mar 25, 2018 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1This transaction represents an open market sale of a portion of the stock options exercised on this Form 4 to satisfy the Reporting Person's payment of the exercise price.